FDA cleared the Vitrification Freeze Kit and Thawing Kit (CS-IVF-FK; CS-IVF-TK) from CELL STORE (BEIJING) BIOTECHNOLOGY CO., LTD. on Aug 28, 2026 under K254261, a traditional 510(k). The device falls under product code MQL, Media, Reproductive, regulated at 21 CFR 884.6180 as a Class 2 device. The review panel was Obstetrics/Gynecology.

FDA logged the submission as received on Dec 30, 2025. The decision came 241 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for CELL STORE (BEIJING) BIOTECHNOLOGY CO., LTD. in the last 12 months of the tracker.